These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 35725915)
1. A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer. Hozhabri H; Moghaddam MM; Moghaddam MM; Mohammadian A Sci Rep; 2022 Jun; 12(1):10374. PubMed ID: 35725915 [TBL] [Abstract][Full Text] [Related]
2. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis. Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008 [TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: evidence from comprehensive bioinformatic analysis. Li Y; Chen X; Li D; Yang Z; Bai Y; Hu S; Liu Z; Gu J; Zhang X BMC Urol; 2021 Dec; 21(1):173. PubMed ID: 34893045 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the prognostic value of glutathione S-transferases Mu family members in breast cancer. Gohari N; Abbasi E; Akrami H Cell Biol Int; 2024 Sep; 48(9):1313-1325. PubMed ID: 38922769 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma. Li Y; Wu T; Gong S; Zhou H; Yu L; Liang M; Shi R; Wu Z; Zhang J; Li S Front Oncol; 2020; 10():570736. PubMed ID: 33489879 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment. Chen B; Zhang S; Li Q; Wu S; He H; Huang J Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700 [TBL] [Abstract][Full Text] [Related]
7. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment. Yin Z; Ma T; Chen S; Yu M Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma. Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K Front Oncol; 2021; 11():711402. PubMed ID: 34497764 [TBL] [Abstract][Full Text] [Related]
9. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer. Liu F; Wu H J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Fibroblast Growth Factor Receptor (FGFR) Family Genes in Breast Cancer by Integrating Online Databases and Bioinformatics. Zhou Z; Wu B; Tang X; Ke R; Zou Q Med Sci Monit; 2020 May; 26():e923517. PubMed ID: 32381997 [TBL] [Abstract][Full Text] [Related]
11. Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis. Mehraj U; Alshehri B; Khan AA; Bhat AA; Bagga P; Wani NA; Mir MA Clin Breast Cancer; 2022 Aug; 22(6):567-578. PubMed ID: 35585016 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer. Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599 [TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer. Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974 [TBL] [Abstract][Full Text] [Related]
14. Bioinformatics, Molecular Docking and Experiments Wang F; Yuan C; Wu HZ; Liu B; Yang YF Front Oncol; 2021; 11():665080. PubMed ID: 34123826 [TBL] [Abstract][Full Text] [Related]
15. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer. Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194 [TBL] [Abstract][Full Text] [Related]
16. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma. Wu HT; Liu J; Li GW; Shen JX; Huang YT Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis. Wu JR; Zhao Y; Zhou XP; Qin X Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer. Liu L; Yang J; Wang C Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744318 [TBL] [Abstract][Full Text] [Related]
19. Investigating novel biomarkers in uterine corpus endometrial carcinoma: in silico analysis and clinical specimens validation via RT-qPCR and immunohistochemistry. Li J; Ramzan F; Zhong G Am J Cancer Res; 2023; 13(9):4376-4400. PubMed ID: 37818076 [TBL] [Abstract][Full Text] [Related]
20. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy. Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]